Falotico R - Search Results

1

Simultaneous monitoring of bemoradan pharmacokinetics and hemodynamics in mongrel dogs.

Huang SM, Falotico R, Haertlein B, Smith IL. Huang SM, et al. Among authors: falotico r. Biopharm Drug Dispos. 1992 Oct;13(7):539-47. doi: 10.1002/bdd.2510130707. Biopharm Drug Dispos. 1992. PMID: 1489944

2

Synthesis and SAR of 6-substituted purine derivatives as novel selective positive inotropes.

Press JB, Falotico R, Hajos ZG, Sawyers RA, Kanojia RM, Williams L, Haertlein B, Kauffman JA, Lakas-Weiss C, Salata JJ. Press JB, et al. Among authors: falotico r. J Med Chem. 1992 Nov 27;35(24):4509-15. doi: 10.1021/jm00102a001. J Med Chem. 1992. PMID: 1335073

3

6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents.

Combs DW, Rampulla MS, Bell SC, Klaubert DH, Tobia AJ, Falotico R, Haertlein B, Lakas-Weiss C, Moore JB. Combs DW, et al. Among authors: falotico r. J Med Chem. 1990 Jan;33(1):380-6. doi: 10.1021/jm00163a061. J Med Chem. 1990. PMID: 2153210

4

Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.

Falotico R, Haertlein BJ, Lakas-Weiss CS, Salata JJ, Tobia AJ. Falotico R, et al. J Cardiovasc Pharmacol. 1989 Sep;14(3):412-8. doi: 10.1097/00005344-198909000-00009. J Cardiovasc Pharmacol. 1989. PMID: 2476620

5

Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine.

Falotico R, Keiser J, Haertlein B, Cheung WM, Tobia A. Falotico R, et al. Proc Soc Exp Biol Med. 1989 Feb;190(2):179-85. doi: 10.3181/00379727-190-42847. Proc Soc Exp Biol Med. 1989. PMID: 2915996

6

Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.

Damiano BP, Giardino EC, Haertlein BJ, Stump GL, Mitchell JA, Falotico R. Damiano BP, et al. Among authors: falotico r. J Cardiovasc Pharmacol. 1994 Feb;23(2):300-10. J Cardiovasc Pharmacol. 1994. PMID: 7511761

7

Novel thieno[2,3-b]- and [3,4-b]pyrans as potassium channel openers. Thiophene systems--XVII.

Press JB, McNally JJ, Sanfilippo PJ, Addo MF, Loughney D, Giardino E, Katz LB, Falotico R, Haertlein BJ. Press JB, et al. Among authors: falotico r. Bioorg Med Chem. 1993 Dec;1(6):423-35. doi: 10.1016/s0968-0896(00)82153-7. Bioorg Med Chem. 1993. PMID: 8087564

8

Heteroatom analogues of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones.

Combs DW, Rampulla MS, Demers JP, Falotico R, Moore JB. Combs DW, et al. Among authors: falotico r. J Med Chem. 1992 Jan;35(1):172-6. doi: 10.1021/jm00079a023. J Med Chem. 1992. PMID: 1732525

9

Renal vasodilators. The role of the 4-substituent in isoquinolin-3-ol cardiovascular agents: 4-ureido derivatives of isoquinolin-3-ol with selective renal vasodilator properties.

Kanojia RM, Lever OW Jr, Press JB, Williams L, Werblood HM, Giardino EC, Falotico R, Tobia AJ. Kanojia RM, et al. Among authors: falotico r. J Med Chem. 1989 May;32(5):990-7. doi: 10.1021/jm00125a011. J Med Chem. 1989. PMID: 2709385

10

Cardiotonic agents. Synthesis and inotropic activity of a series of isoquinolin-3-ol derivatives.

Kanojia RM, Press JB, Lever OW Jr, Williams L, McNally JJ, Tobia AJ, Falotico R, Moore JB Jr. Kanojia RM, et al. Among authors: falotico r. J Med Chem. 1988 Jul;31(7):1363-8. doi: 10.1021/jm00402a020. J Med Chem. 1988. PMID: 3385731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters